非传染性疾病中的自然自调节剂:从自机制到治疗潜力
Ting-Ting Xu1, Ying-Yi Deng1, Xi-Yong Yu2
1NMPA Key Laboratory for Clinical Research and Evaluation of Drug for Thoracic Diseases, Key Laboratory of Molecular Target & Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, China.
Acta pharmacologica Sinica
|August 1, 2024
概括
调节自 (细胞过程) 的天然化合物显示出治疗癌症和糖尿病等非传染性疾病 (NCD) 的前景. 本综述探讨了它们在非传染性疾病中的治疗潜力.
科学领域:
- 生物医学科学 生物医学科学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非传染性疾病 (NCD) 代表着与生活方式因素相关的重大全球健康负担.
- 自是一种细胞降解过程,在主要非传染性疾病的发病过程中起着关键作用.
- 自调节是NCD的潜在治疗策略.
研究的目的:
- 审查NCDs自然自调节器的最新进展.
- 总结这些化合物的体外和体内实验发现.
- 确定具有NCD治疗潜力的自然自调节剂.
主要方法:
- 科学文章的文学评论. 科学文章的文献评论.
- 对自然产品和自的体外和体内研究的分析.
- 专注于像白醇,黄素和乌尔索酸这样的化合物.
主要成果:
- 包括白醇,黄素和乌尔索酸在内的天然产品被认为是强大的自调节剂.
- 证据支持这些化合物在调节与非传染性疾病相关的自途径中的作用.
- 许多研究表明,在临床前模型中,天然自调节剂的治疗潜力.
结论:
- 自然自调节剂是NCD治疗的有希望的途径.
- 需要进一步的研究和临床研究才能充分发挥其治疗潜力.
- 用天然产品准自可以为控制心血管疾病,癌症和糖尿病提供新的策略.
相关概念视频
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Delivery Pathways to the Lysosome
6.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Electron Transport Chain: Complex I and II
12.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.6K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


